Be part of the knowledge - Global Cardiology Academy

Medical News

Medical News
Both Virtual and in-Person Nutrition Visits Help to Lower Cholesterol, Study Finds
medicalxpress.com
12/07/2023
Read more
Medical News
Replacing Bone Saws with Smart Lasers
unibas.ch
12/07/2023
Read more
Medical News
Texas A&M Receives $1.8 Million NIH Grant to Support Bone Health in People with Down Syndrome
today.tamu.edu
12/06/2023
Read more

See more news

Video Demo: Cardiopulmonary Exercise Testing in Pulmonary Arterial Hypertension - Part 1
Video Demo: Cardiopulmonary Exercise Testing in Pulmonary Arterial Hypertension - Part 1
MinuteCE®
Video Demo: Cardiopulmonary Exercise Testing in Pulmonary Arterial Hypertension - Part 1
4.25 program credits
- Christopher B. Cooper, MD, PhD
  Peer
- Alexander Sherman, MD
  Peer
4.25 program credits
Overview of New ERS/ESC Guideline Recommendations
Overview of New ERS/ESC Guideline Recommendations
MinuteCE®
Overview of New ERS/ESC Guideline Recommendations
4.25 program credits
- Richard N. Channick, MD
  Peer
4.25 program credits
Case Study: CTD-PAH
Case Study: CTD-PAH
MinuteCE®
Case Study: CTD-PAH
4.25 program credits
- Siyuan Cao, MD
  Peer
4.25 program credits
Focus on CTD-PAH and Rheumatology
Focus on CTD-PAH and Rheumatology
MinuteCE®
Focus on CTD-PAH and Rheumatology
4.25 program credits
- Suzanne Kafaja, MD
  Peer
- Siyuan Cao, MD
  Peer
- Michael Lewis, MD
  Peer
- Rajan Saggar, MD
  Peer
- Shelley Shapiro, MD, PhD
  Peer
- Antoine Hage, MD
  Peer
- Richard N. Channick, MD
  Peer
4.25 program credits
Focus on Lung-Disease Associated PH
Focus on Lung-Disease Associated PH
MinuteCE®
Focus on Lung-Disease Associated PH
4.25 program credits
- Rajan Saggar, MD
  Peer
- Houda Boucekkine, MD
  Peer
- Yuri Matusov, MD
  Peer
- Sivagini Ganesh, MD, MPH
  Peer
- Shelley Shapiro, MD, PhD
  Peer
4.25 program credits
Link Between Parenchymal Lung Disease and PH
Link Between Parenchymal Lung Disease and PH
MinuteCE®
Link Between Parenchymal Lung Disease and PH
4.25 program credits
- Rajan Saggar, MD
  Peer
4.25 program credits

Programs

Case Study: CPET
Case Study: CPET
MinuteCE®
Case Study: CPET
4.25 program credits
- Adam J. Brownstein, MD
  Peer
4.25 program credits
Pulmonary Hypertension in Rheumatic Diseases - Part 2
Pulmonary Hypertension in Rheumatic Diseases - Part 2
MinuteCE®
Pulmonary Hypertension in Rheumatic Diseases - Part 2
4.25 program credits
- Suzanne Kafaja, MD
  Peer
4.25 program credits
Focus on CTEPH/CTED
Focus on CTEPH/CTED
MinuteCE®
Focus on CTEPH/CTED
4.25 program credits
- Richard N. Channick, MD
  Peer
- Khushboo Goel, MD
  Peer
- Michael Troy, MD
  Peer
- Sonia Jasuja, MD
  Peer
- Christopher B. Cooper, MD, PhD
  Peer
- Michael Lewis, MD
  Peer
4.25 program credits
Pulmonary Hypertension in Rheumatic Diseases - Part 1
Pulmonary Hypertension in Rheumatic Diseases - Part 1
MinuteCE®
Pulmonary Hypertension in Rheumatic Diseases - Part 1
4.25 program credits
- Suzanne Kafaja, MD
  Peer
4.25 program credits
MinuteCE®
West Regional Pulmonary Hypertension Summit – A Case-Based Look At Diagnosis and Treatment
4.25 credits 15 episodes
- Richard N. Channick, MD
  Peer
- Rajan Saggar, MD
  Peer
- Houda Boucekkine, MD
  Peer
- Adam J. Brownstein, MD
  Peer
- Siyuan Cao, MD
  Peer
- Christopher B. Cooper, MD, PhD
  Peer
- Sivagini Ganesh, MD, MPH
  Peer
- Khushboo Goel, MD
  Peer
- Antoine Hage, MD
  Peer
- Brandon Jakubowski, MD
  Peer
- Sonia Jasuja, MD
  Peer
- Suzanne Kafaja, MD
  Peer
- Michael Lewis, MD
  Peer
- Yuri Matusov, MD
  Peer
- Shelley Shapiro, MD, PhD
  Peer
- Alexander Sherman, MD
  Peer
- Michael Troy, MD
  Peer
4.25 credits 15 episodes
Clinical Implications of Updated Heart Failure Nomenclature Part 1
Clinical Implications of Updated Heart Failure Nomenclature Part 1
CME/CE
Clinical Implications of Updated Heart Failure Nomenclature Part 1
0.25 credits
- Lee R. Goldberg, MD, MPH, FACC, FAHA, FHFSA
  Peer
0.25 credits
Lysosomal Storage Disorders: Recognizing and Addressing a Group of Rare Conditions
Lysosomal Storage Disorders: Recognizing and Addressing a Group of Rare Conditions
CME/CE
Lysosomal Storage Disorders: Recognizing and Addressing a Group of Rare Conditions
1.00 credit
- Sarah Viall, MSN, PPCNP-BC
  Peer
- Neal Weinreb, MD, FACP
  Peer
1.00 credit
Combined ESC Guidelines for the Entire ACS Spectrum
Combined ESC Guidelines for the Entire ACS Spectrum
Heart Matters
Combined ESC Guidelines for the Entire ACS Spectrum

Clinical Practice

Case Study: CTEPH
Case Study: CTEPH
MinuteCE®
Case Study: CTEPH
4.25 program credits
- Michael Troy, MD
  Peer
4.25 program credits
Diagnosis & Treatment of Chronic Thromboembolic Pulmonary Hypertension
Diagnosis & Treatment of Chronic Thromboembolic Pulmonary Hypertension
MinuteCE®
Diagnosis & Treatment of Chronic Thromboembolic Pulmonary Hypertension
4.25 program credits
- Sonia Jasuja, MD
  Peer
4.25 program credits
Case Study: Group 3 PH Pulmonary Hypertension Due to Chronic Lung Disease
Case Study: Group 3 PH Pulmonary Hypertension Due to Chronic Lung Disease
MinuteCE®
Case Study: Group 3 PH Pulmonary Hypertension Due to Chronic Lung Disease
4.25 program credits
- Houda Boucekkine, MD
  Peer
4.25 program credits
First ESC Guidelines on Cardiomyopathies Management
First ESC Guidelines on Cardiomyopathies Management
Heart Matters
First ESC Guidelines on Cardiomyopathies Management
First ESC Guidelines on Cardiomyopathies - Diagnosis
First ESC Guidelines on Cardiomyopathies - Diagnosis
Heart Matters
First ESC Guidelines on Cardiomyopathies - Diagnosis
Main Messages of New ESC Guidelines for CVD Management in Diabetes
Main Messages of New ESC Guidelines for CVD Management in Diabetes
Heart Matters
Main Messages of New ESC Guidelines for CVD Management in Diabetes
Identifying Cardiovascular Risk Factors for HIV Patients
Identifying Cardiovascular Risk Factors for HIV Patients
Heart Matters
Identifying Cardiovascular Risk Factors for HIV Patients
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
  Peer
- Steve Grinspoon, MD
  Peer
Exploring Emerging Non-Statin LDL Lowering Therapies
Exploring Emerging Non-Statin LDL Lowering Therapies
Heart Matters
Exploring Emerging Non-Statin LDL Lowering Therapies
- Alan S. Brown, MD, FACC, FAHA, FNLA
  Peer
- Maya S. Safarova, MD, PhD, FNLA
  Peer

CME

Clinical Implications of Updated Heart Failure Nomenclature Part 2
Clinical Implications of Updated Heart Failure Nomenclature Part 2
CME/CE
Clinical Implications of Updated Heart Failure Nomenclature Part 2
0.25 credits
- Lee R. Goldberg, MD, MPH, FACC, FAHA, FHFSA
  Peer
0.25 credits
Increasing the Uptake of Flu Vaccines Across the Age and Risk Spectrum
Increasing the Uptake of Flu Vaccines Across the Age and Risk Spectrum
CME/CE
Increasing the Uptake of Flu Vaccines Across the Age and Risk Spectrum
1.00 credit
- Mary Knudtson, DNSc, NP, FAAN
  Peer
- Martin C. Mahoney, MD, PhD
  Peer
1.00 credit
Transformation of Treatment Strategies for ATTR Amyloidosis
Transformation of Treatment Strategies for ATTR Amyloidosis
Heart Matters
Transformation of Treatment Strategies for ATTR Amyloidosis
Aficamten in Patients With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (REDWOOD-HCM Cohort 4)
Aficamten in Patients With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (REDWOOD-HCM Cohort 4)
MinuteCE®
Aficamten in Patients With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (REDWOOD-HCM Cohort 4)
1.25 program credits
- Ahmad Masri, MD, MS
  Peer
1.25 program credits
WHO? Characterizing Vericiguat Use in a Real-World HFrEF Patient Population
WHO? Characterizing Vericiguat Use in a Real-World HFrEF Patient Population
MinuteCE®
WHO? Characterizing Vericiguat Use in a Real-World HFrEF Patient Population
1.25 program credits
- Marat Fudim, MD, MHS
  Peer
1.25 program credits
Efficacy and Safety of Macitentan Tadalafil Fixed Dose Combination in Pulmonary Arterial Hypertension: Results From the Phase III A DUE Study
Efficacy and Safety of Macitentan Tadalafil Fixed Dose Combination in Pulmonary Arterial Hypertension: Results From the Phase III A DUE Study
MinuteCE®
Efficacy and Safety of Macitentan Tadalafil Fixed Dose Combination in Pulmonary Arterial Hypertension: Results From the Phase III A DUE Study
1.25 program credits
- Kelly Chin, MD
  Peer
1.25 program credits
Consistent Benefit of Rivaroxaban Early and Late After Lower Extremity Revascularization
Consistent Benefit of Rivaroxaban Early and Late After Lower Extremity Revascularization
MinuteCE®
Consistent Benefit of Rivaroxaban Early and Late After Lower Extremity Revascularization
1.25 program credits
- Marc P. Bonaca, MD, MPH
  Peer
1.25 program credits
Applicability of the GALACTIC-HF Trial and Omecamtiv Mecarbil to Patients Hospitalized for Heart Failure in the US: The GWTG-HF Registry
Applicability of the GALACTIC-HF Trial and Omecamtiv Mecarbil to Patients Hospitalized for Heart Failure in the US: The GWTG-HF Registry
MinuteCE®
Applicability of the GALACTIC-HF Trial and Omecamtiv Mecarbil to Patients Hospitalized for Heart Failure in the US: The GWTG-HF Registry
1.25 program credits
- Stephen J. Greene, MD, FACC, FHFSA
  Peer
1.25 program credits